WSJ
12 Aug 2026, 11:39 UTC · 2h ago
Eli Lilly Sues Sellers of Black Market Weight-Loss Drugs
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
WSJ
12 Aug 2026, 11:39 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
Eli Lilly has filed six lawsuits against U.S. entities allegedly selling its investigational weight-loss drug on the black market. — Black market activity indicates leakage of proprietary supply and potential safety/regulatory risks that could complicate the drug's formal rollout.
-0.20Which stocks this story touches
The company is facing challenges with the black market sale of its investigational weight-loss drug.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Reuters
4h ago
